💊 ยา A-Z 🧬 เป้าหมาย 🛠 เครื่องมือ 📚 คู่มือ
ยาทั้งหมด หมวดหมู่ยา ด้านการรักษา ผลข้างเคียง
คู่มือ อภิธานศัพท์ ไทม์ไลน์
การเปรียบเทียบ เส้นทางของยา กลุ่มยา
🇺🇸 English 🇰🇷 한국어 🇯🇵 日本語 🇨🇳 中文简体 🇪🇸 Español 🇧🇷 Português 🇮🇳 हिन्दी 🇸🇦 العربية 🇫🇷 Français 🇷🇺 Русский 🇩🇪 Deutsch 🇹🇷 Türkçe 🇻🇳 Tiếng Việt 🇮🇩 Bahasa Indonesia 🇹🇭 ไทย

Rauwolfia Serpentina

CHEMBL3559672 Phase 4 ได้รับการอนุมัติ Unknown
Half-Life
—
Bioavailability
—
Protein Binding
—
Molecular Weight
— g/mol
LogP
—
Phase
4

Rauwolfia serpentina is a botanical preparation derived from the snakeroot plant containing alkaloids including reserpine that deplete catecholamine neurotransmitters (norepinephrine, dopamine, serotonin) from vesicular storage sites in both central and peripheral neurons, reducing sympathetic tone and blood pressure. It has been used traditionally and clinically for the treatment of hypertension and was one of the first effective antihypertensive agents available.

ด้านการรักษา

Hypertension Cardiovascular Disease

Pharmacokinetics (PK)

Pharmacodynamics (PD)

HBD / HBA

- / -

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

คำถามที่พบบ่อย

Rauwolfia serpentina is a botanical preparation derived from the snakeroot plant containing alkaloids including reserpine that deplete catecholamine neurotransmitters (norepinephrine, dopamine, serotonin) from vesicular storage sites in both central and peripheral neurons, reducing sympathetic tone and blood pressure. It has been used traditionally and clinically for the treatment of hypertension and was one of the first effective antihypertensive agents available.

Yes, Rauwolfia Serpentina is an approved drug. It has reached clinical phase 4. It is classified as a Unknown.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL3559672. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.

ข้อจำกัดความรับผิดชอบทางการแพทย์

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.